Combined symptom index and second-generation multivariate biomarker test for prediction of ovarian cancer in patients with an adnexal mass

The combination of a patient-reported symptom index and refined biomarker panel allows for improved accuracy in the assessment for ovarian cancer in patients with an adnexal mass. This strategy could offer a personalized approach to addressing ROM to triage patients with an adnexal mass to appropriate care.